妊娠期糖尿病中胎盘肌醇降低:葡萄糖改变胎盘肌醇转运体与IMPA1酶表达
该病例对照研究检测足月单胎胎盘(GDM 24例、非GDM 26例)并体外培养9例胎盘,发现GDM胎盘肌醇含量低17%,母体孕中期血糖越高胎盘肌醇越低,高血糖下调IMPA1及SLC5A11、SLC2A13表达,胎盘肌醇高时可减弱空腹血糖与出生体重百分位的正相关。
要点
- GDM胎盘肌醇含量较非GDM低17%,提示胎盘肌醇代谢异常。
- 母体血糖升高伴随胎盘IMPA1及SLC5A11、SLC2A13表达下降。
- 高胎盘肌醇可减弱空腹血糖与定制出生体重百分位的正相关。
核心结论
- 糖基化诱导的胎盘肌醇合成与转运失调可能参与GDM胎盘肌醇含量降低,并可能促进胎儿加速生长。
研究设计与样本
- 足月单胎妊娠胎盘病例对照研究,GDM 24例、非GDM 26例。
- 另取9例胎盘在不同浓度葡萄糖和肌醇中培养48小时。
- 胎盘肌醇用Megazyme法测定,酶与转运体表达用定量RT-PCR和免疫印迹检测。
- 线性回归校正母亲年龄、体质指数、种族、孕龄和胎儿性别。
主要发现
- GDM胎盘肌醇含量较非GDM低17%。
- 母体孕中期血糖越高,胎盘肌醇越低。
- 空腹血糖升高与IMPA1、SLC5A11、SLC2A13蛋白水平降低相关,其表达也与胎盘肌醇含量相关。
- 体外高葡萄糖浓度降低IMPA1和SLC5A11的mRNA表达。
- 低胎盘肌醇者空腹血糖与定制出生体重百分位正相关,高胎盘肌醇时该关联减弱。
临床怎么用
- 对GDM孕妇应重视血糖控制,以减轻对胎盘肌醇合成与转运的不利影响。
- 胎盘肌醇水平可能作为评估胎儿生长过度的潜在生物学标志,但尚需进一步验证。
局限性
- 为病例对照研究,样本量有限(GDM 24例、非GDM 26例),不能确立因果。
- 体外实验仅9例胎盘,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Perturbed inositol physiology in insulin-resistant conditions has led to proposals of inositol supplementation for gestational diabetes (GDM) prevention, but placental inositol biology is poorly understood. OBJECTIVE: Investigate associations of maternal glycemia with placental inositol content, determine glucose effects on placental expression of inositol enzymes and transporters, and examine relations with birthweight. DESIGN AND PARTICIPANTS: Case-control study of placentae from term singleton pregnancies (GDM n = 24, non-GDM n = 26), and culture of another 9 placentae in different concentrations of glucose and myo-inositol for 48 hours. MAIN OUTCOME MEASURES: Placental inositol was quantified by the Megazyme assay. Relative expression of enzymes involved in myo-inositol metabolism and plasma membrane inositol transport was determined by quantitative RT-PCR and immunoblotting. Linear regression analyses were adjusted for maternal age, body mass index, ethnicity, gestational age, and sex. RESULTS: Placental inositol content was 17% lower in GDM compared with non-GDM. Higher maternal mid-gestation glycemia were associated with lower placental inositol. Increasing fasting glycemia was associated with lower protein levels of the myo-inositol synthesis enzyme, IMPA1, and the inositol transporters, SLC5A11 and SLC2A13, the expression of which also correlated with placental inositol content. In vitro, higher glucose concentrations reduced IMPA1 and SLC5A11 mRNA expression. Increasing fasting glycemia positively associated with customized birthweight percentile as expected in cases with low placental inositol, but this association was attenuated with high placental inositol. CONCLUSION: Glycemia-induced dysregulation of placental inositol synthesis and transport may be implicated in reduced placental inositol content in GDM, and this may in turn be permissive to accelerated fetal growth.
引用
- Pillai RA, Islam MO, Selvam P, et al. Placental Inositol Reduced in Gestational Diabetes as Glucose Alters Inositol Transporters and IMPA1 Enzyme Expression. J Clin Endocrinol Metab. 2021. PMID: 33165596. doi:10.1210/clinem/dgaa814
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。